Patent details
EP2672986 Title: LYOPHILIZED FORMULATIONS
Basic Information
- Publication number:
- EP2672986
- PCT Application Number:
- US2012024452
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP127447829
- PCT Publication Number:
- WO2012109429
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- LYOPHILIZED FORMULATIONS
- French Title of Invention:
- FORMULATIONS LYOPHILISÉES
- German Title of Invention:
- LYOPHILISIERTE FORMULIERUNGEN
- SPC Number:
Dates
- Filing date:
- 09/02/2012
- Grant date:
- 18/03/2020
- EP Publication Date:
- 18/12/2013
- PCT Publication Date:
- 16/08/2012
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 18/03/2020
- EP B1 Publication Date:
- 18/03/2020
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 09/02/2021
- Expiration date:
- 09/02/2032
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 11/03/2020
- Name:
- GlaxoSmithKline LLC
- Address:
- 251 Little Falls Drive, Wilmington, DE 19808, United States (US)
Inventor
1
- Name:
- KRANZ, James
- Address:
- United States (US)
2
- Name:
- RINELLA, Joseph
- Address:
- United States (US)
Priority
- Priority Number:
- 201161440918 P
- Priority Date:
- 09/02/2011
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 38/16; A61K 38/26; A61K 39/395; C07K 16/22; C07K 16/24; C07K 16/28;
Publication
European Patent Bulletin
- Issue number:
- 202012
- Publication date:
- 18/03/2020
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|